Filing Details

Accession Number:
0000921895-15-002855
Form Type:
4
Zero Holdings:
No
Publication Time:
2015-12-23 16:50:23
Reporting Period:
2015-12-21
Filing Date:
2015-12-23
Accepted Time:
2015-12-23 16:50:23
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1540729 Foresight Energy Lp FELP Bituminous Coal & Lignite Mining (1220) 800778894
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1211729 Accipiter Life Sciences Fund Lp C/O Candens Services, Inc.
525 Washington Blvd., 33Rd Floor
Jersey City NJ 07310
No No Yes No
1214706 Ltd Offshore Fund Sciences Life Accipiter C/O Candens Services, Inc.
525 Washington Blvd., 33Rd Floor
Jersey City NJ 07310
No No Yes No
1280190 Accipiter Capital Management, Llc 3801 Pga Blvd.
Suite 600
Palm Beach Gardens FL 33408
No No Yes No
1322420 Gabe Hoffman 3801 Pga Blvd.
Suite 600
Palm Beach Gardens FL 33408
No No Yes No
1351609 Candens Capital Llc 3801 Pga Blvd.
Suite 600
Palm Beach Gardens FL 33408
No No Yes No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Units Acquisiton 2015-12-21 2,345 $2.82 3,500,756 No 4 P Indirect By Accipiter Life Sciences Fund, LP
Common Units Acquisiton 2015-12-21 2,162 $2.82 4,682,029 No 4 P Indirect By Accipiter Life Sciences Fund (Offshore), Ltd.
Common Units Acquisiton 2015-12-22 10,399 $2.89 3,511,155 No 4 P Indirect By Accipiter Life Sciences Fund, LP
Common Units Acquisiton 2015-12-22 9,588 $2.89 4,691,617 No 4 P Indirect By Accipiter Life Sciences Fund (Offshore), Ltd.
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Accipiter Life Sciences Fund, LP
No 4 P Indirect By Accipiter Life Sciences Fund (Offshore), Ltd.
No 4 P Indirect By Accipiter Life Sciences Fund, LP
No 4 P Indirect By Accipiter Life Sciences Fund (Offshore), Ltd.
Footnotes
  1. This Form 4 is filed jointly by Accipiter Life Sciences Fund, LP ("ALS Fund"), Accipiter Life Sciences Fund (Offshore), Ltd. ("ALS Offshore"), Accipiter Capital Management, LLC ("Accipiter Management"), Candens Capital, LLC ("Candens Capital"), and Gabe Hoffman (collectively, the "Reporting Persons").
  2. Each Reporting Person may be deemed to be a member of a group that owns more than 10% of the Issuer's outstanding Common Units. Each Reporting Person disclaims beneficial ownership of the Common Units reported herein except to the extent of his or its pecuniary interest therein, and this report shall not be deemed to be an admission that any Reporting Person is the beneficial owner of such Common Units for purposes of Section 16 or for any other purpose.
  3. Common Units directly owned by ALS Fund. Accipiter Management, as the investment manager of ALS Fund, may be deemed to be the beneficial owner of the Common Units directly owned by ALS Fund. Each of Candens Capital, as the general partner of ALS Fund, and Mr. Hoffman, as the managing member of each of Candens Capital and Accipiter Management, may be deemed to be the beneficial owner of the Common Units directly owned by ALS Fund.
  4. Common Units directly owned by ALS Offshore. Accipiter Management, as the investment manager of ALS Offshore, may be deemed to be the beneficial owner of the Common Units directly owned by ALS Offshore. Mr. Hoffman, as the managing member of Accipiter Management, may be deemed to be the beneficial owner of the Common Units directly owned by ALS Offshore.
  5. The price reported in Column 4 is a weighted average price. These Common Units were purchased in multiple transactions at prices ranging from $2.82 to $2.83. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Units purchased at each separate price within the ranges set forth in footnotes 5 and 6 to this Form 4.
  6. The price reported in Column 4 is a weighted average price. These Common Units were purchased in multiple transactions at prices ranging from $2.85 to $2.93. The Reporting Persons undertake to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of Common Units purchased at each separate price within the ranges set forth in footnotes 5 and 6 to this Form 4.